NRX Pharmaceuticals (NRXP) Q4 2023 Earnings

28MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.16
-0.12
-0.09
-0.05

Details

Expected EPS
-0.07
Actual EPS
-0.05
Surprise EPS
0.02
Surprise Percent
+28.57%

Description

NRX Pharmaceuticals (NRXP) has reported earnings of -0.05 per share for Q4 2023.

0 Comments

Share your thoughts